70 mg/dL

PROCEDURE2 trials

Sponsors

Kobe University Graduate School of Medicine, Assistance Publique - Hôpitaux de Paris

Conditions

Atherosclerotic StenosisIschemic StrokeTransient Ischemic Attackvulnerable plaque in patients with coronary artery disease

Unknown Phase

Treat Stroke to Target

CompletedNCT01252875

Assistance Publique - Hôpitaux de ParisAtherosclerotic Stenosis, Ischemic Stroke, Transient Ischemic Attack

Start: 2010-03-15End: 2019-05-26Updated: 2019-08-06

Efficacy of Alirocumab for Thin-cap fibroatheroma in patients with coronary artery disease estImated by optical coherence tomography trial.

Active, not recruitingJPRN-UMIN000029533

Kobe University Graduate School of Medicinevulnerable plaque in patients with coronary artery disease

Start: 2017-09-26Target: 24Updated: 2026-06-29

Related Papers

More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke

Stroke2023-06-289 citations

Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial

Stroke2022-09-2621 citations

Intracranial Hemorrhage in the TST Trial

Stroke2021-12-2922 citations

Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin

Circulation2020-06-2936 citations

Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke

Stroke2020-03-1855 citations

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

New England Journal of Medicine2019-11-18542 citations

Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokes

European Stroke Journal2019-03-2618 citations